# Ilika secures first commercial Stereax electrode order from Cirtec Medical

- Link: https://www.directorstalkinterviews.com/ilika-secures-first-commercial-stereax-electrode-order-from-cirtec-medical/4121235898
- Published: 2026-01-21T07:17:33+00:00
- Author: Amilia Stone

**[Ilika plc](https://www.directorstalkinterviews.com/company/ilika-plc/ika.l)**(
[LON:IKA](https://www.directorstalkinterviews.com/company/ilika-plc/ika.l)), the
UK pioneer in solid state battery technology, has secured its first revenue-generating
purchase order from Cirtec Medical for the supply of Stereax electrodes, marking
the commercial transition of this strategic partnership. This milestone order for
the critical conductive elements that enable battery functionality follows two years
of development work and successful prototype delivery in December 2025.

The Stereax electrodes will support the ramp up of Stereax M300 production at Cirtec,
targeting a wide range of applications across active implantable medical devices(
AIMDs), including powering implanted sensors, neurostimulators, orthopaedic implants,
orthodontic wearables and ophthalmology devices. This purchase represents Ilika’s
entry into the commercial phase of its medical device battery technology.

In August 2023, Ilika announced an agreement whereby the Company would retain specific
battery manufacturing processes at its UK facility as a service to Cirtec. After
successfully delivering early versions of Stereax M300 batteries in December 2025(
with primary manufacturing occurring at Cirtec’s Massachusetts facility), this relationship
has now progressed to commercial orders, with Cirtec purchasing production quantities
of electrodes from Ilika. The Stereax M300 batteries are currently being evaluated
by 21 customers for their applications.

> **Shawn Martin, Vice President at Cirtec Medical, said:** “_This marks an important
> transition from the earlier stages of technology transfer to commercial production
> coordinated from our facility here in the USA.”_

> **Graeme Purdy, CEO of Ilika, said:** _“__The receipt of this first commercial
> electrode order validates the strong market momentum building behind our Stereax
> technology and demonstrates the successful execution of our production strategy.
> This revenue-generating phase of our partnership with Cirtec positions us to support
> their manufacturing scale-up while accelerating product integration across numerous
> high-value medical device applications.”_

The companies will showcase their partnership at upcoming industry events, with 
Ilika supporting Cirtec at the North America Neuromodulation Society (NANS) annual
meeting in Las Vegas on January 23-24, 2026. Additionally, Cirtec will exhibit and
represent Stereax technology at MD&M West in Anaheim on February 3-5, 2026, further
highlighting the commercial readiness of this innovative battery solution.

Share on: